Tri Locum Partners LP Xenon Pharmaceuticals Inc. Transaction History

Tri Locum Partners LP

$387 Million
Q2 2024

A detailed history of Tri Locum Partners LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Tri Locum Partners LP holds 101,959 shares of XENE stock, worth $3.94 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

101,959

Previous 207,465 50.85%

Holding current value

$3.94 Million

Previous $8.93 Million 55.49%

% of portfolio

1.03%

Previous 3.21%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $3.82 Million - $4.62 Million	-105,506 Reduced 50.85%	101,959 $3.98 Million
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $772,103 - $905,673	-18,099 Reduced 8.02%	207,465 $8.93 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $1.54 Million - $2.5 Million	53,809 Added 31.33%	225,564 $10.4 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $5.04 Million - $5.86 Million	147,534 Added 609.12%	171,755 $5.87 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $6.88 Million - $8.6 Million	-197,509 Reduced 89.08%	24,221 $932,000
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $4.3 Million - $5.18 Million	128,366 Added 137.49%	221,730 $7.94 Million
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $1.35 Million - $1.62 Million	-40,967 Reduced 30.5%	93,364 $3.68 Million
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $987,373 - $1.28 Million	-32,068 Reduced 19.27%	134,331 $4.85 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $4.23 Million - $5.85 Million	166,399 New	166,399 $5.06 Million
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $628,328 - $829,674	-25,043 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $3.73 Million - $8.46 Million	-239,091 Reduced 90.52%	25,043 $782,000
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $3.93 Million - $5.14 Million	264,134 New	264,134 $4.04 Million

Others Institutions Holding XENE

# of Institutions

221

Shares Held

69.6M

Call Options Held

59.7K

Put Options Held

60.7K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.41B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Account

Tri Locum Partners LP Xenon Pharmaceuticals Inc. Transaction History